Generic Portal

TY - JOUR

T1 - Tissues attached to retrieved leadless pacemakers

T2 - Histopathological evaluation of tissue composition in relation to implantation time and complications

AU - Breeman, Karel T. N.

AU - du Long, Romy

AU - Beurskens, Niek E. G.

AU - van der Wal, Allard C.

AU - Wilde, Arthur A. M.

AU - Tjong, Fleur V. Y.

AU - Knops, Reinoud E.

N1 - Funding Information: Funding sources: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publisher Copyright: © 2021 Heart Rhythm Society Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/12

Y1 - 2021/12

N2 - Background: Leadless pacemakers (LPs) have proven safe and effective, but device revisions remain necessary. Either replacing the LP or implanting a new adjacent LP is feasible. Replacement seems more appealing, but encapsulation and tissue adhesions may hamper the safety and efficacy of LP retrieval. Objective: We determined the incidence and cellular characteristics of tissue adherent to retrieved LPs and the potential implications for end-of-life strategy. Methods: All 15 consecutive successful Nanostim LP retrievals in a tertiary center were included. We assessed the histopathology of adherent tissue and obtained clinical characteristics. Results: Adherent tissue was present in 14 of 15 retrievals (93%; median implantation duration 36 months; range 0–96 months). The tissue consisted of fibrosis (n = 2), fibrosis and thrombus (n = 9), or thrombus only (n = 3). In short-term retrievals (<1 year), mostly fresh thrombi without fibrosis were seen. In later retrievals, the tissue consisted of fibrosis often with organizing or lytic thrombi. Fibrosis showed different stages of organization, notably early fibrocellular and later fibrosclerotic tissue. Inflammatory cells were seen (n = 4) without signs of infection. Tricuspid valve material was retrieved in 1 patient after 36 months, resulting in increased tricuspid regurgitation. Conclusion: Our results suggest that fibrosis and thrombus adherent to LPs are common and encapsulate the LP as seen in transvenous pacemakers. LPs may adhere to the tricuspid valve or subvalvular apparatus affecting retrieval safety. The end-of-life strategy should be optimized by incorporating risk stratification for excessive fibrotic encapsulation and adhesions.

AB - Background: Leadless pacemakers (LPs) have proven safe and effective, but device revisions remain necessary. Either replacing the LP or implanting a new adjacent LP is feasible. Replacement seems more appealing, but encapsulation and tissue adhesions may hamper the safety and efficacy of LP retrieval. Objective: We determined the incidence and cellular characteristics of tissue adherent to retrieved LPs and the potential implications for end-of-life strategy. Methods: All 15 consecutive successful Nanostim LP retrievals in a tertiary center were included. We assessed the histopathology of adherent tissue and obtained clinical characteristics. Results: Adherent tissue was present in 14 of 15 retrievals (93%; median implantation duration 36 months; range 0–96 months). The tissue consisted of fibrosis (n = 2), fibrosis and thrombus (n = 9), or thrombus only (n = 3). In short-term retrievals (<1 year), mostly fresh thrombi without fibrosis were seen. In later retrievals, the tissue consisted of fibrosis often with organizing or lytic thrombi. Fibrosis showed different stages of organization, notably early fibrocellular and later fibrosclerotic tissue. Inflammatory cells were seen (n = 4) without signs of infection. Tricuspid valve material was retrieved in 1 patient after 36 months, resulting in increased tricuspid regurgitation. Conclusion: Our results suggest that fibrosis and thrombus adherent to LPs are common and encapsulate the LP as seen in transvenous pacemakers. LPs may adhere to the tricuspid valve or subvalvular apparatus affecting retrieval safety. The end-of-life strategy should be optimized by incorporating risk stratification for excessive fibrotic encapsulation and adhesions.

KW - Encapsulation

KW - End-of-life

KW - Histopathology

KW - Leadless pacemaker

KW - Nanostim

UR - http://www.scopus.com/inward/record.url?scp=85115918804&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2021.08.025

DO - 10.1016/j.hrthm.2021.08.025

M3 - Article

C2 - 34461305

VL - 18

SP - 2101

EP - 2109

JO - Heart rhythm

JF - Heart rhythm

SN - 1547-5271

IS - 12

ER -